Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
 
Articles by Andrzej Rynkiewicz
Total Records ( 3 ) for Andrzej Rynkiewicz
  Andrzej Rynkiewicz , Barbara Cybulska , Maciej Banach , Krzysztof Filipiak , Tomasz Guzik , Barbara Idzior-Walus , Jacek Imiela , Piotr Jankowski , Longina Kłosiewicz-Latoszek , Janusz Limon , Małgorzata Myśliwiec , Grzegorz Opolski , Andrzej Steciwko , Janina Stepinska and Tomasz Zdrojewski
  Heterozygous familial hypercholesterolemia (HFH) affects on average 1 in 500 individuals in European countries, and it is estimated that HeFH in Poland may affect more than 80,000 people. Cardiovascular mortality in individuals with FH between 20 and 39 years of age is 100 times higher than in the general population. HFH is a relatively common lipid disorder, but usually still remaining undiagnosed and untreated. A very high risk of cardiovascular diseases and a shortened lifespan in patients with this condition require early diagnosis and intensive treatment. The aim of the position paper was to present the importance and scale of this problem in Poland, which has not been raised enough so far, as well as the recommendations of diagnosis, treatment and prevention methods.
  Małgorzata Mysliwiec , Mieczysław Walczak , Ewa Małecka-Tendera , Anna Dobrzanska , Barbara Cybulska , Krzysztof Filipiak , Artur Mazur , Przemysława Jarosz-Chobot , Agnieszka Szadkowska , Andrzej Rynkiewicz , Alicja Chybicka , Piotr Socha , Agnieszka Brandt , Joanna Bautembach-Minkowska , Tomasz Zdrojewski , Janusz Limon , Samuel S. Gidding and Maciej Banach
  Familial hypercholesterolemia (FH) affects on average 1 in 500 individuals in European countries, and it is estimated that FH in Poland may affect more than 80,000 people. However, in Poland, only about 20% of the population is estimated to have been diagnosed with FH, of which only a small number receive adequate treatment. FH results in more rapid development of atherosclerosis and is associated with a high risk of cardiovascular events. Atherosclerosis develops beginning in childhood in patients with FH and reaches advanced stages before clinical manifestations develop. Inadequate diagnostics and treatment of FH in Polish children suggests a need for raising the level of awareness and understanding of the condition in both society and among health professionals. These recommendations present the current epidemiological status, guidelines for diagnosing FH in Polish children and adolescents, and effective treatment options.
  Danuta Makowiec , Aleksandra Dudkowska , Rafał Galaska and Andrzej Rynkiewicz
 

Two popular estimators of multifractal properties: the Wavelet Transform Modulus Maxima method and Multifractal Detrended Fluctuation Analysis are applied to investigate signals consisting of normal RR-series in 39 healthy subjects and 90 patients suffering from systolic dysfunction of the left ventricle. However, differently from standards for multifractal analysis the scaling is performed separately in intervals corresponding to standard power spectral bands: low (LF), very low (VLF) and ultra low frequencies (ULF). Tests on fractional Brownian motions (fBm) are done to quantify properties of the estimators as detectors of monofractality in LF, VLF and ULF bands. Arguments are given that multifractal analysis of RR-series performed in these bands has a physiological meaning. The increased activation of the sympathetic nervous system caused by heart disease is detected evidently only by analysis in LF. The transition in multifractal characteristics between diurnal and nocturnal activity takes place when the analysis moves from LF and VLF to ULF. Only in ULF, the diurnal heart rate variability can be approximated by fBm with a self-similarity index of H=0.20 .

 
 
 
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility